A61K 9/12
Aerosols
Official title: Aerosols; Foams {(A61K9/0043, A61K9/0056, A61K9/006, A61K9/0073 take precedence; spray-films A61K9/7015)}
A61K9/12 (Aerosols) appears on 1,338 US grants and 2,281 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,338
- Published applications
- 2,281
- Assignees
- 1,011
- Inventors
- 3,022
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 10 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 4 | 0 |
| 1997 | 26 | 0 |
| 1998 | 13 | 0 |
| 1999 | 25 | 0 |
| 2000 | 16 | 0 |
| 2001 | 18 | 10 |
| 2002 | 30 | 33 |
| 2003 | 21 | 61 |
| 2004 | 39 | 87 |
| 2005 | 15 | 64 |
| 2006 | 58 | 76 |
| 2007 | 12 | 67 |
| 2008 | 20 | 71 |
| 2009 | 20 | 63 |
| 2010 | 21 | 84 |
| 2011 | 20 | 72 |
| 2012 | 42 | 80 |
| 2013 | 47 | 100 |
| 2014 | 80 | 95 |
| 2015 | 64 | 98 |
| 2016 | 54 | 101 |
| 2017 | 73 | 138 |
| 2018 | 60 | 112 |
| 2019 | 71 | 155 |
| 2020 | 89 | 138 |
| 2021 | 73 | 118 |
| 2022 | 59 | 108 |
| 2023 | 54 | 117 |
| 2024 | 64 | 87 |
| 2025 | 46 | 91 |
| 2026 | 29 | 55 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cosmetic compositions for skin health and methods of using same11 Aug 2026US 12,702,638 B2Locus Solutions Ipco, LLC
- Method for reducing side effects from administration of phosphodiesterase-4 inhibitors4 Aug 2026US 12,697,329 B2Arcutis Biotherapeutics, Inc.
- Therapeutic carbon monoxide formulations28 Jul 2026US 12,691,140 B2Beth Israel Deaconess Medical Center, Inc.
- Aerosol comprising 5-methoxy-N,N-dimethyltryptamine21 Jul 2026US 12,685,721 B2Gh Research Ireland Limited
- Method for reducing side effects from administration of phosphodiesterase-4 inhibitors21 Jul 2026US 12,685,727 B2Arcutis Biotherapeutics, Inc.
- Corticosteroid nanosuspensions and uses thereof1 Oct 2026US 2026/0294934 A1Aimmax Therapeutics, Inc.
- Cartridge for Housing a Production of a Therapeutic Microfoam, Automated Device, Method for Producing a Therapeutic Microfoam, and Microfoam24 Sep 2026US 2026/0283952 A1
- Recombinant protein compositions useful for wound healing10 Sep 2026US 2026/0263559 A1Wake Forest University Health Sciences
- Metered dose inhalers and high-dose suspensions27 Aug 2026US 2026/0249027 A1Kindeva Drug Delivery L. P.
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions20 Aug 2026US 2026/0240898 A1Adora Life Science, Inc.
Most cited
By later US patents
- Drug administration method1,497US 7,427,607 B2Next21 K.K. · 2008
- Foam substrate and micropackaged active ingredient particle composite dispensing materials1,078US 4,828,542 ATwin Rivers Engineering · 1989
- Mesocellular oxide foams as hemostatic compositions and methods of use1,075US 8,202,549 B2The Regents of the University of California · 2012
- Antigen-adjuvant compositions and methods1,024US 8,790,658 B2Sanofi Pasteur Limited · 2014
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001